Skip to main content

Market Overview

GenMark Surges On Report Of Potential Takeover Amid Interest From Buyers: Bloomberg

  • Bloomberg stated that GenMark Diagnostics Inc (NASDAQ: GNMK) is reportedly exploring a sale and has been contacted by multiple potential buyers. The company is said to have engaged a financial advisor to help it navigate acquisition discussions. Though GenMark hasn’t made any public statements about the report at this point.
  • According to Cowen, the company could be a “solid fit” for large diagnostics firms, including Hologic, Becton Dickinson, Thermo Fisher Scientific, and Roche. A deal price in the range of $20 to $25 per share “appears reasonable,” analysts including Doug Schenkel wrote in a research note.
  • GenMark expects to report revenue of about $171 million for 2020, a 95% increase from a year ago.
  • According to the data compiled, Fidelity Investments, BlackRock Inc., and Vanguard Group are among GNMK’s top shareholders.
  • GenMark sale could potentially add to a wave of deal making activity among diagnostics companies, which have benefitted from the surge in demand for coronavirus testing. 
  • Price Action: GNMK shares moved 26.3% higher at $21.29 in trading hours on the last check Thursday.

Related Articles (HOLX + GNMK)

View Comments and Join the Discussion!

Posted-In: BloombergM&A News Health Care Rumors Small Cap Top Stories General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at